Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02550483 · ClinicalTrials.gov registry record · NA

Novel Metabolites of Beta-Carotene and Lycopene

A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT02550483 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02550483, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

The study (n = 36) will be a parallel design and will be 6 weeks in duration. Participants will start with a 2-week free-living wash-in period where they will be asked to avoid certain carotenoid-rich foods, followed by 4 weeks of a completely controlled diet. In addition to the controlled diet, participants will consume one of three beverages (300 mL/day; n = 12/group): placebo beverage (control), high beta-carotene tomato juice, and high-lycopene tomato juice. Blood, urine and feces will be collected throughout the study.

Interventions

  • OTHER Base diet + high beta-carotene tomato juice
  • OTHER Base diet + high lycopene tomato juice
  • OTHER Base diet + placebo beverage

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2015-09
Est. Completion 2015-11
Phase NA

What the Registry Record Tells You About NCT02550483

The ClinicalTrials.gov registry entry for NCT02550483 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA Beltsville Human Nutrition Research Center, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Base diet + high beta-carotene tomato juice is the first listed.

NCT02550483 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02550483 about?

NCT02550483 is a clinical study titled "Novel Metabolites of Beta-Carotene and Lycopene". The study (n = 36) will be a parallel design and will be 6 weeks in duration. Participants will start with a 2-week free-living wash-in period where they will be asked to avoid certain carotenoid-rich foods, followed by 4 weeks of a completely controlled diet. In addition to the controlled diet, par...

What is the current status of trial NCT02550483?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-09. Estimated completion is 2015-11.

What interventions are being tested in trial NCT02550483?

The interventions under investigation include: Base diet + high beta-carotene tomato juice (OTHER), Base diet + high lycopene tomato juice (OTHER), Base diet + placebo beverage (OTHER).

Who is sponsoring clinical trial NCT02550483?

This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.